The purpose of this study is to assess the efficacy and safety of Transoral Incisionless
Fundoplication (TIF) performed with EsophyX as compared to proton pump inhibitor (PPI)
therapy for the treatment of chronic Gastroesophageal Reflux Disease (GERD) patients with
refractory symptoms on Proton Pump Inhibitors (PPIs).